• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经母细胞瘤中1p36染色体的等位基因缺失优先源自母系,且与N-myc扩增相关。

Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.

作者信息

Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voûte P A, Westerveld A, Versteeg R

机构信息

Institute of Human Genetics, Academic Medical Centre, University of Amsterdam, The Netherlands.

出版信息

Nat Genet. 1993 Jun;4(2):187-90. doi: 10.1038/ng0693-187.

DOI:10.1038/ng0693-187
PMID:8102298
Abstract

Neuroblastomas frequently have deletions of chromosome 1p and amplification of the N-myc oncogene. We analysed 53 neuroblastomas for the N-myc copy number, loss of heterozygosity (LOH) of chromosome 1p36 and the parental origin of the lost alleles. Allelic loss of 1p36 was found in 15 tumours. All N-myc amplified tumours belonged to this subset. In 13/15 tumours with LOH of 1p36 the lost allele was of maternal origin. This non-random distribution implies that the two alleles of the putative neuroblastoma suppressor gene on chromosome 1p36 are functionally different, depending on their parental origin. This is the first evidence as far as we know for genomic imprinting on chromosome 1p.

摘要

神经母细胞瘤常常存在1号染色体短臂缺失以及N - myc癌基因扩增。我们分析了53例神经母细胞瘤的N - myc拷贝数、1号染色体短臂36区杂合性缺失(LOH)以及缺失等位基因的亲本来源。在15例肿瘤中发现了1号染色体短臂36区的等位基因缺失。所有N - myc扩增的肿瘤都属于这一亚组。在15例1号染色体短臂36区杂合性缺失的肿瘤中,有13例缺失的等位基因来自母本。这种非随机分布意味着1号染色体短臂36区假定的神经母细胞瘤抑制基因的两个等位基因在功能上是不同的,这取决于它们的亲本来源。据我们所知,这是1号染色体上基因组印记的首个证据。

相似文献

1
Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.神经母细胞瘤中1p36染色体的等位基因缺失优先源自母系,且与N-myc扩增相关。
Nat Genet. 1993 Jun;4(2):187-90. doi: 10.1038/ng0693-187.
2
Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.人类神经母细胞瘤中N - myc基因父本等位基因的优先扩增。
Nat Genet. 1993 Jun;4(2):191-4. doi: 10.1038/ng0693-191.
3
Analysis of genomic imprinting at 1p35-36 in neuroblastoma.神经母细胞瘤中1p35 - 36区域的基因组印记分析。
Med Pediatr Oncol. 2001 Jan;36(1):52-5. doi: 10.1002/1096-911X(20010101)36:1<52::AID-MPO1014>3.0.CO;2-8.
4
Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.利用短串联重复多态性分析神经母细胞瘤中1p染色体位点缺失及微卫星不稳定性
Cancer Res. 1995 Dec 1;55(23):5681-6.
5
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.在伴有N-myc扩增的神经母细胞瘤中父本等位基因的优先扩增。
Prog Clin Biol Res. 1994;385:43-9.
6
Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group.通过聚合酶链反应分析及N-myc扩增对48例神经母细胞瘤中假定的肿瘤抑制基因位点1p36缺失情况进行研究:德国神经母细胞瘤研究组的结果
Prog Clin Biol Res. 1994;385:19-25.
7
Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.神经母细胞瘤细胞系中的缺失图谱表明,1p35 - 36区域存在两个不同的肿瘤抑制基因,其中只有一个与N - myc扩增相关。
Oncogene. 1995 Jan 19;10(2):291-7.
8
Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.1号或14号染色体杂合性缺失可定义晚期神经母细胞瘤的亚型。
Cancer Res. 1992 Apr 1;52(7):1780-5.
9
Allelotype of neuroblastoma.神经母细胞瘤的等位基因型
Oncogene. 1995 Nov 2;11(9):1829-34.
10
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.11q23位点的等位基因缺失在MYCN单拷贝神经母细胞瘤中很常见。
Oncogene. 1999 Sep 2;18(35):4948-57. doi: 10.1038/sj.onc.1202887.

引用本文的文献

1
Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities.HDAC1 和 HDAC2 之间的附带致死作用利用了癌症特异性 NuRD 复合物的脆弱性。
Nat Struct Mol Biol. 2023 Aug;30(8):1160-1171. doi: 10.1038/s41594-023-01041-4. Epub 2023 Jul 24.
2
Non-Coding RNAs in Pediatric Solid Tumors.小儿实体瘤中的非编码RNA
Front Genet. 2019 Sep 20;10:798. doi: 10.3389/fgene.2019.00798. eCollection 2019.
3
Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma.恩曲替尼及其他用于治疗神经母细胞瘤的ALK/TRK抑制剂。
Drug Des Devel Ther. 2018 Oct 23;12:3549-3561. doi: 10.2147/DDDT.S147384. eCollection 2018.
4
Genetic susceptibility to neuroblastoma: current knowledge and future directions.神经母细胞瘤的遗传易感性:当前的认识和未来的方向。
Cell Tissue Res. 2018 May;372(2):287-307. doi: 10.1007/s00441-018-2820-3. Epub 2018 Mar 27.
5
Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification.采用下一代测序技术对 MYCN 未扩增的神经母细胞瘤体细胞突变进行综合检测的临床评估。
Oncotarget. 2017 Jul 25;8(30):49689-49701. doi: 10.18632/oncotarget.17917.
6
Research progress of neuroblastoma related gene variations.神经母细胞瘤相关基因变异的研究进展
Oncotarget. 2017 Mar 14;8(11):18444-18455. doi: 10.18632/oncotarget.14408.
7
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.神经母细胞瘤转化基因组学的进展:从改善风险分层、揭示新生物学特性到识别可操作的基因组改变。
Cancer. 2016 Jan 1;122(1):20-33. doi: 10.1002/cncr.29706. Epub 2015 Nov 5.
8
Pyrosequencing for accurate imprinted allele expression analysis.焦磷酸测序用于准确的印记等位基因表达分析。
J Cell Biochem. 2015 Jul;116(7):1165-70. doi: 10.1002/jcb.25081.
9
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification.功能型 MYCN 特征可预测神经母细胞瘤的预后,而与 MYCN 扩增无关。
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19190-5. doi: 10.1073/pnas.1208215109. Epub 2012 Oct 22.
10
dsPIG: a tool to predict imprinted genes from the deep sequencing of whole transcriptomes.dsPIG:一种从全转录组深度测序中预测印记基因的工具。
BMC Bioinformatics. 2012 Oct 19;13:271. doi: 10.1186/1471-2105-13-271.